glp 1 and glp 2 drugs 1: Just a wonder drug or a lifesaver for millions? GLP-1 medication and its types
Description
Our study included any GLP-1 receptor agonists that were prescribed during the study period in Ontario, Canada
S.et al (2014)
One of Novo Nordisk's biggest risks, however, is the potential for generics
In November 2023, the rate of discontinuations due to medication availability peaked at 14.6%
2 They are also associated with a significant potential to lower A1C
Safety and effects of anti-obesity medications on weight loss, cardiometabolic, and psychological outcomes in people living with overweight or obesity: a systematic review and meta-analysis
